Part 1: Featured interview with BioPharm International
Clinical care and clinical research are deeply connected in oncology—and timely, high-quality data can help strengthen both.
In part one of ConcertAI’s four-part interview series with BioPharm International, Eron Kelly, CEO, and Shaalan Beg, MD, CMO of Oncology, discuss how ConcertAI is advancing CancerLinQ with AI and real-world data to deliver faster, more actionable clinical insights. By bringing together structured and unstructured information from across the patient journey, the platform can help oncology teams identify clinical trial opportunities, support clinical decision-making, and accelerate research.
They also explore how an EHR- and vendor-agnostic approach can bring together information from multiple sources, helping practices put harmonized data and insights to work across both patient care and clinical research.
Watch the interview to learn how ConcertAI is helping bridge clinical care and research through real-world data.